News
BBP
86.20
+2.72%
2.28
ImmunityBio Stock Climbs As FDA Accepts Expanded Use Filing For Bladder Cancer Drug
Benzinga · 20h ago
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
Seeking Alpha · 2d ago
Weekly Report: what happened at BBP last week (0511-0515)?
Weekly Report · 3d ago
Weekly Report: what happened at BBP last week (0504-0508)?
Weekly Report · 05/11 09:19
Weekly Report: what happened at BBP last week (0427-0501)?
Weekly Report · 05/04 09:18
Medical Technology Stocks: Innovation Endures As Valuations Reset
Seeking Alpha · 05/02 12:39
Weekly Report: what happened at BBP last week (0420-0424)?
Weekly Report · 04/27 09:19
Weekly Report: what happened at BBP last week (0413-0417)?
Weekly Report · 04/20 09:18
Weekly Report: what happened at BBP last week (0406-0410)?
Weekly Report · 04/13 09:19
Global PMI: Tracking The Sectors Hit Hardest By The Middle East War
Seeking Alpha · 04/12 05:10
Can Forgotten Biotech Break Out?
Seeking Alpha · 04/11 04:30
Weekly Report: what happened at BBP last week (0330-0403)?
Weekly Report · 04/06 09:19
Weekly Report: what happened at BBP last week (0323-0327)?
Weekly Report · 03/30 09:19
ImmunityBio Lead Bladder Cancer Drug Trial Clears Power Check
Benzinga · 03/26 14:04
Weekly Report: what happened at BBP last week (0316-0320)?
Weekly Report · 03/23 09:18
ImmunityBio Stock Jumps As New Bladder Cancer Guideline Boosts Anktiva Use
Benzinga · 03/17 17:54
Weekly Report: what happened at BBP last week (0309-0313)?
Weekly Report · 03/16 09:18
Why Is ImmunityBio Stock Soaring On Friday?
Benzinga · 03/13 14:44
ImmunityBio Announces FDA Resubmission For Expanded Use Of Lead Drug
Benzinga · 03/09 15:03
Weekly Report: what happened at BBP last week (0302-0306)?
Weekly Report · 03/09 09:18
More
Webull provides a variety of real-time BBP stock news. You can receive the latest news about Virtus LifeSci Biotech Products ETF through multiple platforms. This information may help you make smarter investment decisions.